invention

Teen Scientist Working on Parkinson’s Treatment

In North Texas, bright young minds are hard at work and one in particular may be on the verge of shaping the future for patients with Parkinson’s disease.

At 14 years old, it seems there’s nothing Anushka Sridhar hasn’t done.

“Outside of school, I play volleyball, basketball, I’m a third-degree black belt in taekwondo. I do an Indian cultural dance and I’m also part of Destination Imagination,” the Plano ISD 8th grader said.

Sridhar is also a budding scientist, who won the grand prize in her school’s science fair.

She created a device designed to lessen the tremors experienced by Parkinson’s patients.

“My great aunt passed away. With her tremors though, she had a lot of difficulties just with daily activity,” Sridhar said. “So that sparked an idea for me to try and create like a wrist band that could mitigate the tremors.”

For two months, she dove head first into researching Parkinson’s disease, a neurological disorder that causes hand tremors and imbalance.

She learned about how vibration therapy can help the motor skills of Parkinson’s patients.

The idea is the vibrations fool the brain and distract it from the physical sensation of tremors so that patients have an easier time writing.

It’s a well-known theory that even the goliaths of the industry, like Microsoft, are looking into.

Sridhar used common materials, like velcro and simple curcuits to create a prototype wristband. She reached out to the Dallas Area Parkinsonism Society, or DAPS, for test subjects willing to strap on her homemade wristband.

“They were excited that a young person would take that kind iof interest. You can’t help but be impressed when you hear her,” DAPS Executive Director Mike Miles said.

The partnership blossomed, and Sridhar connected with people five times her age. Each one seem impressed with the device, that not only worked, but gave them hope!

“I’m sure she will study that and improve on it and one day, we will have a device that we could put on and write normally,” said 81-year-old Ryan Wagner of Plano.

Sridhar said she planned to expand her research and build more prototypes of her wristband.

She hopes to one day affect the lives of every Parkinson’s patient.

She now advances to the Plano ISD district fair and the Dallas regional science fair.

Article from NBCDFW.

Read more

Your Parkinson’s tremor printed in 3D

Parkinson’s Life talk to two of the creatives behind ‘Printed by Parkinson’s’, a Berlin-based art collection that saw 3D printers ‘affected’ with the data of six people with Parkinson’s in order to replicate their individual tremors – and visualise the everyday difficulties facing people with the condition


A team of creatives from Berlin, Germany, are combining art, technology and Parkinson’s in an innovative new fundraising project.

As part of the project, organisers asked six people living with Parkinson’s to choose an object that they found difficult to use due to their symptoms. The team then used kinetic and neurological data to create a 3D printer which mirrored their personal Parkinson’s symptoms, and printed each object in bronze – creating art that reflects their struggles with the condition.

We spoke to Reiner Gorissen and Marlon von Franquemont, the two creatives behind the fundraiser.

Hello, thanks for talking to Parkinson’s Life. What’s your story and your connection to Parkinson’s?

Hi, I’m Reinier Gorissen and this is Marlon von Franquemont. We’re creatives who work at INNOCEAN Berlin. We produce advertising campaigns for global brands, but also try to find projects that could help important causes.

We started the ‘Printed by Parkinson’s’ project after a colleague had two family members diagnosed with Parkinson’s. We realised that, like most people, we didn’t know anything about the condition – and we wanted to change that.

How did you come up for the concept of ‘Printed by Parkinson’s’?

R.G: While planning, we learned about the Parkinson’s research projects conducted by Charité, one of Europe’s biggest university hospitals, and decided to put our minds together to support them.

We wanted to create a concept that would educate people about Parkinson’s and support the research at the same time. When we brought the ‘Printed by Parkinson’s’ idea to Charité, they instantly embraced it.

Who worked on this project with you? 

M.V.F: The project brings the medical, tech and art world together. It was overwhelming to see how all involved parties embraced our initiative and worked long hours to make it happen.

Charité involved their patients by recording their data, production company MediaMonks was responsible for the 3D printing and the project’s website and creative content agency Cosmopola produced the photography and film material. As the initiator of the project, INNOCEAN Berlin created all marketing-related assets and organised the exhibition.

How was the data used to create the 3D models?

R.G: First, we recorded the kinetic and neurological data of the participants using electroencephalography (EEG) systems – which monitor electrical activity in the brain – and accelerometers at Charité.

The production company MediaMonks then turned the data into algorithms, devising one for each participant.

After a long period of testing, we managed to 3D print the objects selected by each patient while the printer was affected by their personal Parkinson’s data.

Why did you settle on 3D printing over more traditional art forms?

R.G: Parkinson’s is a very complex condition and most people don’t know how significant the impact of it is on people’s lives. By using technology and art, we were able to break through the clutter and also engage younger audiences. The art objects instantly give people an idea how Parkinson’s affects lives – and invite people to learn the stories behind the objects.

Why did you think using seemingly simple, everyday objects would make an impact on those outside of the Parkinson’s community?

M.V.F: We believed that the collection would be most impactful if each object portrayed a personal story. That’s why we asked participants to name an object that represented a job, hobby or activity that was affected by the onset of their Parkinson’s.

Most people outside the Parkinson’s community don’t know much about the condition. They often think it only affects older people and don’t know that Parkinson’s has more than 40 symptoms. The ‘Printed by Parkinson’s’ collection visualises the daily struggles that people have with simple tasks like using a pen or a camera.

How was the collection received by the general public, the participants involved – and by people with Parkinson’s? 

M.V.F: The response has been great from all directions. The collection was shared on medical, tech and art platforms all around the world and was broadcasted on multiple TV channels in several different languages.

We also received great feedback from those who took part. On top of that, others showed interest in sharing their story – and we hope it inspires more people to be open about their condition as people must keep sharing their story to make the public aware of the condition.

How much money has been raised so far from sales?

R.G: We have received multiple bids, but unfortunately can’t reveal the digits. Let’s just say we’re very proud of the offers – all of which will go towards research at Charité.

Do you have any plans for further Parkinson’s-related art projects or campaigns?

M.V.F: Definitely. In fact, there are some projects on the way already. Hopefully we’ll be able to share them with you soon.

Printed by Parkinsons's

Reiner Gorissen (left) and Marlon von Franquemont (right), the creatives behind ‘Printed by Parkinson’s’.

This collection was exhibited at gallery Alte Münze, in Berlin for one week in July 2019. For more information on the project, please visit the ‘Printed by Parkinson’s’ website.
Read more

IBM unveils fingernail sensor that can monitor PD

Recently IBM unveiled its latest innovation that could change the way how we monitor health. It’s prototype AI-powered fingernail sensor will let its users place the sensor over their fingernail to detect symptoms and track disease progression.

According to IBM, the innovation can help track cognitive functions in schizophrenics, check the effectiveness of medication in a person with Parkinson’s disease and even individuals’ cardiovascular health.

Although there are skin sensors that can monitor body activities, it is hard to place them on people with Parkinson’s disease as a majority of them are older patients with brittle skin and might lead to infection.

But by shifting the sensors to the nail, not only did they avoid the problem of skin rash that could arise from skin sensors, they were able to track the activities of hand for throughout the day which is a key factor in diagnosing degenerative neurological diseases such as in the case of Parkinson’s disease.

“Our fingernails deform — bend and move — in stereotypic ways when we use them for gripping, grasping, and even flexing and extending our fingers. This deformation is usually on the order of single digit microns and not visible to the naked eye,” said Katsuyuki Sakuma, from IBM’s Thomas J. Watson Research Center in New York.

The system consists of strain gauges attached to the fingernail and a small computer that collects data and communicates with a smart watch, which is equipped with machine learning models to rate bradykinesia, tremor, and dyskinesia which are all symptoms of Parkinson’s disease.

The AI-powered sensor monitors the bending and movement of a patient’s nail to calculate their grip strength. It then transmits the information which includes matters like nail wrap, motions, gestures, finger-writing, grip strength, and activation time from the wearable sensors to an off-finger device for interpretation and draws meaningful insight.

With this invention, IBM says that it is one step closer to materialising their longtime challenge of using AI to help clinicians monitor individuals in their natural environments. “By pushing computation to the end of our fingers, we’ve found a new use for our nails by detecting and characterising their subtle movements,” Sakuma said in closing.

Article from Analytics India Magazine.

Read more

Irish entrepreneur uses technology to fight PD

Ciara Clancy is no ordinary entrepreneur, with her company Beats Medical far less concerned with making money than it is with helping people live with various neurological conditions.

At the age of just 29, Ciara Clancy’s work in helping people to live with the likes of Parkinson’s disease, Alzheimer’s, dyspraxia and the effects of stroke are unparalleled on the island of Ireland.

Speaking to host Tadhg Enright on this week’s The Architects of Business, in partnership with EY Entrepreneur Of The Year™, Ciara reveals the reason why she left behind her career as a physiotherapist.

A highly driven and passionate individual, Ciara wanted to create technology – based on Metronome Therapy, which helps Parkinson’s sufferers in particular – that would make it as easy for those living with these life-changing conditions to get around at home as it would be under medical supervision.

“I remember the exact moment that I decided I wanted to found Beats Medical,” Ciara – a 2016 finalist in the EY Entrepreneur Of The Year™ programme – reveals.

“A person with Parkinson’s disease was coming into me for this Metronome Therapy in a hospital, and he was 20 minutes late and I went out to find him stuck, frozen at the main entrance.

“And this was happening everywhere we went, every door he went through, and I knew that when he came into clinic he walked very well with Metronome Therapy but he’d go home and this would persist, and it was at that point I said I can’t go 20 years into my career and not try. I need to find a way to bring this treatment into the home.

“That’s when I decided to step out of my career as a physio and volunteer with a Parkinson’s charity to understand needs outside of the hospital. And really that’s how Beats Medical was born.”

Article from JOE.ie.

Read more

Next Stop for PD Research: Outer Space

In an effort to find new treatments for Parkinson’s disease, researchers are sending their experiments to space.

On Monday Aug. 14, researchers launched a key Parkinson’s disease protein, called LRRK2, to the International Space Station (ISS). The microgravity conditions in space should offer a better test environment for their experiments with this protein, the researchers said.

The materials for their experiments will travel aboard the SpaceX Dragon capsule as part of a mission to send supplies and science experiments to the ISS.

The work is a collaboration between The Michael J. Fox Foundation for Parkinson’s Research and the Center for the Advancement of Science in Space (CASIS).

LRRK2 is a type of protein that modifies other proteins. Mutations in the gene that codes for LRRK2 are thought to cause Parkinson’s disease in some people. Researchers have hypothesized that developing drugs to inhibit LRRK2, or block its activity, could help prevent Parkinson’s or slow its progression.

But before scientists can develop a drug to inhibit LRRK2, they need to know the precise structure of this protein. One way to get a detailed view of its structure is by growing crystals of LRRK2 in lab dishes. However, on Earth, gravity can interfere with the growth of these crystals, and keep them small.

“The quality of our crystals is just not good enough [on Earth],” Sebastian Mathea, a researcher at the University of Oxford who is involved in the LRRK2 project, said during a news conference about the project Tuesday (Aug. 8).

This is where the ISS research comes in: Researchers hope that the microgravity conditions in space will allow the crystals to grow bigger with fewer defects. The scientists can then get a sharper view of the crystal structure.

Scientists will grow the LRRK2 crystals for about a month in space. Then, the crystals will be sent back to Earth, where they will be analyzed with high-energy X-rays, Mathea said.

Parkinson’s disease is a progressive neurological disorder that affects people’s movement abilities, and can result in symptoms such as tremors, slowed movements and muscle stiffness. There are currently no treatments to stop or reverse the progression of the disease, according to The Michael J. Fox Foundation.

Article from Live Science.

Read more

Microsoft shows off watch that quiets Parkinson’s tremors

SAN FRANCISCO — Tech company developer conferences always feature a wacky demo or three.

But at Build 2017 in Seattle Wednesday, Microsoft went for the waterworks at the conclusion of CEO Satya Nadella’s keynote address: it showcased a prototype watch that temporarily eliminated the arm shaking that often plagues those suffering from the neurological disease Parkinson’s.

After a speech that both heralded and warned about coming leaps in technological power, Nadella screened a video that told the story of two British Microsoft Research employees, Haiyan Zhang and Nicolas Villa, who developed the tremor-interrupting device for a BBC documentary, The Big Life Fix.

Working with graphic designer and Parkinson’s sufferer Emma Lawton, 32, the researchers developed a watch — which they named Emma — that, according to Microsoft, “vibrates in a distinctive pattern to disrupt the feedback loop between brain and hand.”

The video showed Lawton trying to draw a square with her shaky right hand, and then again, wearing Emma. Watson erupts in tears as she calls her mother to say this is the first time she’s been able to write her name in ages.

When the lights went up, Nadella welcomed both Lawton and engineer Zhang on stage, thanking them for showing that thanks “developers can have impact.”

Emma Watch remains a prototype, Microsoft says, but the developers are working with a neuroscience research team to undertake trials with a small group of Parkinson’s sufferers.

The watch works through a combination of sensors and AI (artificial intelligence) techniques to potentially detect and monitor symptoms like tremors, stiffness and instability, among others, according to Microsoft. “Once these symptoms can be identified and measured, it’s possible to develop technology and devices that help humans manage their symptoms. AI is used to classify the sensor information and elicit real-time responses on small devices like wearables.”

Microsoft stresses that Emma Watch is not a cure for the disease, which afflicts 10 million people. “Rather, its technology has the potential to help Parkinson’s patients manage symptoms that impede regular functions. The goal of further research is to determine whether Emma Watch could help other people with similar Parkinson’s symptoms.”

https://www.usatoday.com/story/tech/talkingtech/2017/05/10/microsoft-shows-off-watch-quiets-parkinsons-tremors/101517718/

Read more

Students developing invention to help Parkinson’s Patients

Last fall, WPA was contacted by a group of Project Lead The Way students from Catholic Memorial High School in Waukesha, WI. The students were tasked with “finding a problem they could solve.” Two of the students have seen the challenges of Parkinson’s tremor with their grandparents, so the group decided to work on a product to help people with PD.

WPA invited the group to attend our Brookfield Support Group to present their ideas and ask for feedback from people who would actually use this product. This was a great opportunity for WPA to bring together different generations to talk about a serious everyday challenge we see. We have invited the students to come back and share their prototype once they have it!
Click here to view an article from the Waukesha Freeman Newspaper.
Read more